EUR 3.22
(1.45%)
Year | Eps | Eps Growth |
---|---|---|
2023 | -0.58 EUR | -20.83% |
2022 | -0.48 EUR | -132.0% |
2021 | 1.50 EUR | 157.69% |
2020 | -2.60 EUR | -47.73% |
2019 | -1.76 EUR | 30.98% |
2018 | -2.55 EUR | -35.64% |
2017 | -1.88 EUR | -46.87% |
2016 | -1.28 EUR | -85.51% |
2015 | -0.69 EUR | 9.21% |
2014 | -0.76 EUR | -16.92% |
2013 | -0.65 EUR | -85.71% |
2012 | -0.35 EUR | 53.33% |
2011 | -0.75 EUR | 3.85% |
2010 | -0.78 EUR | -23.81% |
2009 | -0.63 EUR | -85.29% |
2008 | -0.34 EUR | -41.67% |
2007 | -0.24 EUR | -951.06% |
2006 | 0.03 EUR | -81.2% |
2005 | 0.15 EUR | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q2 | 0.61 EUR | 0.0% |
2023 Q3 | - EUR | 100.0% |
2023 FY | - EUR | -20.83% |
2023 Q2 | -0.42 EUR | 0.0% |
2023 Q4 | -0.16 EUR | 0.0% |
2022 Q2 | -0.21 EUR | 0.0% |
2022 Q3 | - EUR | 100.0% |
2022 FY | - EUR | -132.0% |
2022 Q4 | -0.27 EUR | 0.0% |
2021 Q2 | 0.21 EUR | 0.0% |
2021 Q4 | 1.17 EUR | 0.0% |
2021 FY | - EUR | 157.69% |
2020 Q4 | -1.24 EUR | 0.0% |
2020 FY | - EUR | -47.73% |
2020 Q2 | -1.37 EUR | 0.0% |
2019 Q4 | -0.36 EUR | 0.0% |
2019 FY | - EUR | 30.98% |
2019 Q2 | -1.64 EUR | -272.73% |
2019 Q1 | -0.44 EUR | 67.88% |
2018 FY | - EUR | -35.64% |
2018 Q4 | -1.37 EUR | 0.0% |
2018 Q2 | -1.18 EUR | -84.37% |
2018 Q1 | -0.64 EUR | 39.62% |
2017 Q4 | -1.06 EUR | 0.0% |
2017 FY | - EUR | -46.87% |
2017 Q1 | -0.47 EUR | 37.33% |
2017 Q2 | -0.73 EUR | -55.32% |
2016 FY | - EUR | -85.51% |
2016 Q2 | -0.49 EUR | -58.06% |
2016 Q1 | -0.31 EUR | 11.43% |
2016 Q4 | -0.75 EUR | 0.0% |
2015 FY | - EUR | 9.21% |
2015 Q3 | -0.17 EUR | 54.05% |
2015 Q2 | -0.37 EUR | -117.65% |
2015 Q1 | -0.17 EUR | 50.0% |
2015 Q4 | -0.35 EUR | -105.88% |
2014 FY | - EUR | -16.92% |
2014 Q1 | -0.19 EUR | 17.39% |
2014 Q3 | -0.19 EUR | 55.81% |
2014 Q2 | -0.43 EUR | -126.32% |
2014 Q4 | -0.34 EUR | -78.95% |
2013 Q3 | -0.16 EUR | 62.79% |
2013 FY | - EUR | -85.71% |
2013 Q4 | -0.23 EUR | -43.75% |
2013 Q2 | -0.43 EUR | -168.75% |
2013 Q1 | -0.16 EUR | 0.0% |
2012 Q1 | -0.09 EUR | 0.0% |
2012 Q4 | -0.16 EUR | -81.2% |
2012 FY | - EUR | 53.33% |
2012 Q2 | -0.09 EUR | 0.0% |
2012 Q3 | -0.09 EUR | 0.0% |
2011 Q3 | -0.19 EUR | 0.0% |
2011 Q1 | -0.19 EUR | 0.0% |
2011 Q2 | -0.19 EUR | 0.0% |
2011 Q4 | -0.09 EUR | 53.53% |
2011 FY | - EUR | 3.85% |
2010 Q1 | -0.20 EUR | 0.0% |
2010 Q2 | -0.20 EUR | 0.0% |
2010 Q3 | -0.20 EUR | 0.0% |
2010 Q4 | -0.19 EUR | 5.0% |
2010 FY | - EUR | -23.81% |
2009 FY | - EUR | -85.29% |
2009 Q4 | -0.20 EUR | -25.0% |
2009 Q3 | -0.16 EUR | 0.0% |
2009 Q2 | -0.16 EUR | 0.0% |
2009 Q1 | -0.16 EUR | 0.0% |
2008 Q2 | -0.09 EUR | 0.0% |
2008 Q4 | -0.16 EUR | -87.79% |
2008 Q3 | -0.09 EUR | 0.0% |
2008 Q1 | -0.09 EUR | 0.0% |
2008 FY | - EUR | -41.67% |
2007 Q2 | 0.00 EUR | 0.0% |
2007 Q3 | 0.00 EUR | 0.0% |
2007 Q4 | -0.09 EUR | -4157.14% |
2007 FY | - EUR | -951.06% |
2007 Q1 | 0.00 EUR | 0.0% |
2006 Q2 | 0.06 EUR | 0.0% |
2006 Q4 | 0.00 EUR | -96.48% |
2006 FY | - EUR | -81.2% |
2006 Q1 | 0.06 EUR | 0.0% |
2006 Q3 | 0.06 EUR | 0.0% |
2005 Q3 | 0.09 EUR | 0.0% |
2005 FY | - EUR | 0.0% |
2005 Q2 | 0.09 EUR | 0.0% |
2005 Q1 | 0.09 EUR | 0.0% |
2005 Q4 | 0.06 EUR | -31.06% |
2004 Q4 | 0.09 EUR | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
ABIONYX Pharma SA | -0.12 EUR | -383.333% |
ABIVAX Société Anonyme | -3.43 EUR | 83.09% |
Adocia SA | -1.91 EUR | 69.634% |
Aelis Farma SA | -0.39 EUR | -48.718% |
Biophytis S.A. | -12.55 EUR | 95.378% |
Advicenne S.A. | -0.67 EUR | 13.433% |
genOway Société anonyme | 0.17 EUR | 441.176% |
IntegraGen SA | -0.03 EUR | -2139.382% |
Medesis Pharma S.A. | -0.80 EUR | 27.5% |
Neovacs S.A. | -0.00 EUR | -23100.0% |
NFL Biosciences SA | -0.46 EUR | -26.087% |
Plant Advanced Technologies SA | 0.07 EUR | 928.571% |
Quantum Genomics Société Anonyme | -0.09 EUR | -537.363% |
Sensorion SA | -0.17 EUR | -241.176% |
Theranexus Société Anonyme | -0.88 EUR | 34.091% |
TME Pharma N.V. | -1.34 EUR | 56.716% |
Valbiotis SA | -0.59 EUR | 1.695% |
TheraVet SA | -0.49 EUR | -18.367% |
Valerio Therapeutics Société anonyme | -0.15 EUR | -286.667% |
DBV Technologies S.A. | -0.71 EUR | 18.31% |
GeNeuro SA | -0.59 EUR | 1.695% |
Innate Pharma S.A. | -0.09 EUR | -516.366% |
Inventiva S.A. | -2.43 EUR | 76.132% |
MaaT Pharma SA | -1.73 EUR | 66.474% |
MedinCell S.A. | -0.88 EUR | 34.091% |
Nanobiotix S.A. | -1.08 EUR | 46.296% |
OSE Immunotherapeutics SA | -1.18 EUR | 50.847% |
Poxel S.A. | -0.91 EUR | 36.264% |
GenSight Biologics S.A. | -0.54 EUR | -7.407% |
Transgene SA | -0.22 EUR | -163.636% |
Valneva SE | -0.73 EUR | 20.548% |